Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in north indian cohort

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5615-5621

  Jaiswal, Praveen Kumar ^a   Goel, Apul ^b   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Bacillus Calmette Guerin; Bladder cancer; Haplotype; Survival; Survivin gene polymorphism

Indexed keywords

SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

ADULT; ARTICLE; BLADDER CANCER; CANCER GENETICS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECURRENCE RISK; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SURVIVIN GENE; TUMOR GENE; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; DEMOGRAPHY; GENE FREQUENCY; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; IMMUNOTHERAPY; INDIA; KAPLAN MEIER METHOD; MIDDLE AGED; MYCOBACTERIUM BOVIS; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME;

MYCOBACTERIUM BOVIS BCG;

CASE-CONTROL STUDIES; COHORT STUDIES; DEMOGRAPHY; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNOTHERAPY; INDIA; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECURRENCE; RISK FACTORS; SMOKING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84863770322     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1366-1     Document Type: Article

References (28)

1. Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49(3):222-228
2. Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R (2008) Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 615:47-79
3. Altieri DC (2008) Survivin, cancer networks and pathwaydirected drug discovery. Nat Rev Cancer 8(1):61-70
4. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3(1):46-54
5. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917-921
6. Fukuda S, Pelus LM (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5(5):1087-1098
7. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273(18):11177-11182
8. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58(22):5071-5074
9. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ (2001) Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 4:305-310
10. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K (2003) Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97(4):1077-1083
11. Vischioni B, van der Valk P, Span SW, Kruyt FA, Rodriguez JA, Giaccone G (2004) Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann Oncol 15(11):1654-1660
12. Mellai M, Caldera V, Patrucco A, Annovazzi L, Schiffer D (2008) Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res 28(1A): 109-118
13. Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H (2010) Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. J Thorac Oncol 5(11):1748-1754
14. O'Connor DS, Wall NR, Porter AC, Altieri DC (2002) A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2(1):43-54
15. Sharp DJ, Rogers GC, Scholey JM (2000) Microtubule motors in mitosis. Nature 407(6800):41-47
16. Xu Y, Fang F, Ludewig G, Jones G, Jones D (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23(9):527-537
17. Borbély AA, Murvai M, Szarka K, Kónya J, Gergely L, Hernádi Z, Veress G (2007) Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60(3):303-306
18. Jang JS, Kim KM, Kang KH, Choi JE, Lee WK, Kim CH, Kang YM, Kam S, Kim IS, Jun JE, Jung TH, Park JY (2008) Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60(1):31-39
19. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, Dong H, Sun Q, Cong R, Chen G, Wang B (2009) The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 54(5):1021-1028
20. Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH (2009) Association between survivin gene promoter -31C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73(3):670-674
21. Cheng ZJ, Hu LH, Huang SJ (2008) Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma. Ai Zheng 27(3):258-263
22. Colombel M, Soloway M, Akaza H et al (2008) Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol Suppl 7:618-626
23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16(3):1215
24. Han CH, Wei Q, Lu KK, Liu Z, Mills GB, Wang LE (2009) Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. Int J Clin Exp Med 2(4):289-299
25. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2011) Role of survivin gene promoter polymorphism (-31G[C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol 18(3):880-887
26. Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Sato S, Mitobe Y, Narita S, Habuchi T (2010) Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer 129(8):1872-1880
27. Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G (2011) Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among Chinese. PLoS One 6(2):e16748
28. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D (2004) Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 96(13):1030-1036